LaVoieHealthScience Launches PR For Oticon’s Opn, The Most Technologically Advanced Hearing Aid
BOSTON--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions.
“Opn marks a significant advance in hearing aid technology with its ability to provide people with hearing loss better speech understanding*, reduced listening effort*, and more conversation recall** and we’re glad to have LHS on the team.”
The corrected release reads:
LAVOIEHEALTHSCIENCE LAUNCHES PR FOR BREAKTHROUGH HEARING AIDS: OTICON OPN™
New Technology Helps People Hear Better with Less Effort, Better Recall
LaVoieHealthScience (LHS), an award winning integrated strategic communications agency focused on health and life science, announced it won a competitive RFP process and is leading the public relations strategy and execution for the U.S. launch of Oticon Opn™, breakthrough hearing aids designed and manufactured by the world’s leading innovator of BrainHearing™ technology.
“We are thrilled Oticon selected LHS to introduce its new, premium hearing aid, Oticon Opn, to the U.S. market based on our 15 years of proven experience providing effective strategies for our clients,” said Donna LaVoie, President and CEO, LaVoieHealthScience. “Oticon is a global leader with more than a century-long commitment to providing innovative, ground-breaking hearing aid technology to people with hearing loss, and we are humbled and excited to join the team and lead public relations for this new product launch.”
The LaVoieHealthScience team is supporting the launch of Opn by providing media relations strategy and execution both nationally and locally, as well as leading development of a digital PR strategy with digital assets.
“The LHS team, its energy and creativity has proven to be a strong addition to the team leading the launch of Oticon Opn,” said Sheena Oliver, Vice President of Marketing, Oticon, Inc. “Opn marks a significant advance in hearing aid technology with its ability to provide people with hearing loss better speech understanding*, reduced listening effort*, and more conversation recall** and we’re glad to have LHS on the team.”
LaVoieHealthScience began work with Oticon in March 2016. Opn was introduced in the U.S. in April 2016 at the American Academy of Audiology's annual audiologist conference in Phoenix, AZ. Opn will be available through select audiologists in the United States on May 31. More information can be found http://www.oticon.com/.
About Oticon
Oticon is one of the most innovative hearing device manufacturers with more than 110 years of experience putting the needs of people with hearing loss first. Oticon has spearheaded a number of technological breakthroughs which have made a significant difference for people with hearing loss. Oticon’s “brain first” audiological focus recognizes that speech understanding and comprehension are cognitive processes that happen in the brain. Oticon’s innovative BrainHearing™ technology is helping to provide better hearing with less effort by giving the brain the clearest, purest sound signals to decode. Oticon designs and manufactures hearing solutions for adults and specialized pediatric instruments. People First is Oticon’s strongest and most valued commitment to empower people to communicate freely, interact naturally and participate actively. For more information visit: http://www.oticon.com/.
About LaVoieHealthScience
LaVoieHealthScience partners
with leading life science brands to build value for their companies,
attract capital and reach key stakeholders through integrated
communications and marketing. The firm provides strategic
communications, investor relations and public relations to build
recognition and increase sales and value for health science innovations.
The agency has received 27 awards over the past six years in recognition
of the work it has done for its industry-leading clients. The agency
maintains a comprehensive list of investor, partnering and medical
conferences which can be found here.
LaVoieHealthScience is ranked by O’Dwyer’s PR as one of the Top 30 Independent Healthcare PR firms in the US.
*Compared to Alta2 Pro
**Individual benefit may vary depending on instrument prescriptions
LaVoieHealthScience
David Connolly, 617-374-8800 Ext.
108
Senior Vice President
dconnolly@lavoiehealthscience.com